Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seynaeve

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Spine|May 18, 1999
Occipital pain in osteoid osteoma of the atlas. A report of two casesM P De Praeter, G F Dua, P C Seynaeve, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2007
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole]J G H van Nes, C Seynaeve, C J H van de Velde, et al.
Journal of the National Cancer Institute|October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor supportR de Wit, J Verweij, M Bontenbal, et al.
Journal of Hepatology|July 29, 1999
Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cellsD Luo, D Vermijlen, K Vanderkerken, et al.
Sarcoma|January 13, 2010
Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine originA W Oosten, C Seynaeve, P I M Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma GroupR Somers, A Santoro, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patientsL C Verhoog, E M Berns, C T Brekelmans, et al.
Breast Cancer Research and Treatment|May 23, 2001
Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxaneC H Smorenburg, M Bontenbal, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatinP A van Liessum, C Seynaeve, P H de Mulder, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2005
[Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)']A N van Geel, H K Wyrdeman, C Seynaeve, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Spine|May 18, 1999
Occipital pain in osteoid osteoma of the atlas. A report of two casesM P De Praeter, G F Dua, P C Seynaeve, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2007
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole]J G H van Nes, C Seynaeve, C J H van de Velde, et al.
Journal of the National Cancer Institute|October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor supportR de Wit, J Verweij, M Bontenbal, et al.
Journal of Hepatology|July 29, 1999
Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cellsD Luo, D Vermijlen, K Vanderkerken, et al.
Sarcoma|January 13, 2010
Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine originA W Oosten, C Seynaeve, P I M Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma GroupR Somers, A Santoro, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patientsL C Verhoog, E M Berns, C T Brekelmans, et al.
Breast Cancer Research and Treatment|May 23, 2001
Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxaneC H Smorenburg, M Bontenbal, C Seynaeve, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatinP A van Liessum, C Seynaeve, P H de Mulder, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 12, 2005
[Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)']A N van Geel, H K Wyrdeman, C Seynaeve, et al.
Pageof 11